Issue Contents:  Sep 1, 2010

• Karo Bio Eyes 2011 Start for Eprotirome Pivotal Program
• Stabilitech Inks Deal with U.S. Agency to Stabilize Vaccines
• Scottish Firms Combine Apoptosis, Antibody Expertise
• European Union Slow to Embrace First Cell Therapy
• Rimcazole Trial Stopped After Adverse Reactions Reported
• Other News To Note

      The above issue is also available as one PDF File